Wall Street Experts
| Wartość aktywów (mln USD): | 17 | |||||||||||
| Liczba spółek: | 36 | |||||||||||
| Stopa dywidendy: | - % | |||||||||||
| Opłata za zarządzanie:: | 0.85 % | |||||||||||
| Klasa aktywów: | Equity |
ISIN: US53656G5633
Wystawca ETF: None| Nazwa | Symbol | Klasa_aktywów | Wartość_aktywów | 5D | 1M | 3M | 6M | 2024 | 1R | 3L | 5L | 10L |
|---|
| Sektor | Udział % |
|---|---|
| Technologie Medyczne | 94.7 |
| Gotówka | 4.5 |
| Usługi Dystrybucyjne | 0.6 |
| Usługi Komercyjne | 0.1 |
| Nazwa firmy | Symbol | Wartość | Udział % w portfelu | Ilość akcji |
|---|---|---|---|---|
| Eli Lilly & Co | LLY | 2 479 647 | 18.3 | 3 359 |
| Novartis AG | NVS | 1 015 842 | 7.5 | 9 597 |
| Amgen Inc | AMGN | 988 856 | 7.3 | 3 359 |
| Bristol-Myers Squibb Co | BMY | 981 852 | 7.2 | 17 755 |
| AstraZeneca PLC | AZN | 854 107 | 6.3 | 12 476 |
| US BANK MMDA - USBGFS 7 06/01/2031 | USBGFS7 | 800 643 | 5.9 | 800 643 |
| Johnson & Johnson | JNJ | 782 597 | 5.8 | 5 107 |
| Alkermes PLC | ALKS | 692 372 | 5.1 | 23 033 |
| Alnylam Pharmaceuticals Inc | ALNY | 678 931 | 5.0 | 2 880 |
| Pfizer Inc | PFE | 595 199 | 4.4 | 25 912 |
| Merck & Co Inc | MRK | 547 315 | 4.0 | 6 718 |
| Regeneron Pharmaceuticals Inc | REGN | 412 884 | 3.0 | 720 |
| GSK PLC | GSK | 411 510 | 3.0 | 11 265 |
| Biogen Inc | BIIB | 383 575 | 2.8 | 3 119 |
| CRISPR Therapeutics AG | CRSP | 344 686 | 2.5 | 10 557 |
| Ionis Pharmaceuticals Inc | IONS | 337 975 | 2.5 | 12 476 |
| Beam Therapeutics Inc | BEAM | 146 546 | 1.1 | 9 597 |
| Haleon PLC | HLN | 139 271 | 1.0 | 14 082 |
| Replimune Group Inc | REPL | 107 394 | 0.8 | 14 396 |
| Vanda Pharmaceuticals Inc | VNDA | 107 276 | 0.8 | 25 912 |
| Bicycle Therapeutics PLC | BCYC | 99 188 | 0.7 | 14 396 |
| Intellia Therapeutics Inc | NTLA | 95 445 | 0.7 | 14 396 |
| Lantern Pharma Inc | LTRN | 86 085 | 0.6 | 28 791 |
| 2seventy bio Inc | TSVT | 85 511 | 0.6 | 17 275 |
| Sandoz Group AG | SDZNY | 72 960 | 0.5 | 1 920 |
| Galectin Therapeutics Inc | GALT | 70 939 | 0.5 | 53 742 |
| GE HealthCare Technologies Inc | GEHC | 58 090 | 0.4 | 960 |
| Cash & Other | Cash&Other | 57 146 | 0.4 | 57 146 |
| Editas Medicine Inc | EDIT | 32 620 | 0.2 | 31 670 |
| Allogene Therapeutics Inc | ALLO | 27 639 | 0.2 | 19 194 |
| Viatris Inc | VTRS | 27 219 | 0.2 | 3 572 |
| Pacific Biosciences of California Inc | PACB | 14 166 | 0.1 | 11 517 |
| Bluebird Bio Inc | BLUE | 9 019 | 0.1 | 1 822 |
| Salarius Pharmaceuticals Inc | SLRX | 2 763 | 0.0 | 3 886 |
| Mural Oncology PLC | MURA | 2 604 | 0.0 | 2 304 |
| Pathos AI Inc | 2368714D | 0 | 0.0 | 23 992 |